StockDuty ← Dashboard Sep 01, 2026 06:24 AM ET
CatalystFDA/Bio

Cytokinetics (CYTK) Reaches A Phase 3 First In Non Obstructive HCM

Phase 3 first in non-obstructive HCM marks a pivotal clinical milestone for Cytokinetics.

What changed
Why it matters
Phase 3 first in non-obstructive HCM marks a pivotal clinical milestone for Cytokinetics.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →